Correlation Between Galectin Therapeutics and Contineum Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Galectin Therapeutics and Contineum Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Galectin Therapeutics and Contineum Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Galectin Therapeutics and Contineum Therapeutics, Class, you can compare the effects of market volatilities on Galectin Therapeutics and Contineum Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Galectin Therapeutics with a short position of Contineum Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Galectin Therapeutics and Contineum Therapeutics,.
Diversification Opportunities for Galectin Therapeutics and Contineum Therapeutics,
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Galectin and Contineum is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Galectin Therapeutics and Contineum Therapeutics, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Contineum Therapeutics, and Galectin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Galectin Therapeutics are associated (or correlated) with Contineum Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Contineum Therapeutics, has no effect on the direction of Galectin Therapeutics i.e., Galectin Therapeutics and Contineum Therapeutics, go up and down completely randomly.
Pair Corralation between Galectin Therapeutics and Contineum Therapeutics,
Given the investment horizon of 90 days Galectin Therapeutics is expected to generate 1.13 times more return on investment than Contineum Therapeutics,. However, Galectin Therapeutics is 1.13 times more volatile than Contineum Therapeutics, Class. It trades about 0.13 of its potential returns per unit of risk. Contineum Therapeutics, Class is currently generating about 0.12 per unit of risk. If you would invest 390.00 in Galectin Therapeutics on August 17, 2025 and sell it today you would earn a total of 161.00 from holding Galectin Therapeutics or generate 41.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Galectin Therapeutics vs. Contineum Therapeutics, Class
Performance |
| Timeline |
| Galectin Therapeutics |
| Contineum Therapeutics, |
Galectin Therapeutics and Contineum Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Galectin Therapeutics and Contineum Therapeutics,
The main advantage of trading using opposite Galectin Therapeutics and Contineum Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Galectin Therapeutics position performs unexpectedly, Contineum Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Contineum Therapeutics, will offset losses from the drop in Contineum Therapeutics,'s long position.| Galectin Therapeutics vs. DiaMedica Therapeutics | Galectin Therapeutics vs. Design Therapeutics | Galectin Therapeutics vs. Rocket Pharmaceuticals | Galectin Therapeutics vs. Aura Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |